We conducted astudytoanalyze theeffectiveness oftransnasal esophagoscopy (TNE) asanalternative tooperative endoscopy (OE) for the evaluation ofprimary headand neck cancers and for the surveillance of synchronous esophageal cancers. Our studypopulation wasmade up of96 consecutively presentingpatients-75 men and 21 women, aged45 to88years (mean: 64)-who were treated atourinstitutionforsquamous cell cancer oftheheadand neck. Of this group, 42 patients had been evaluated with TNEand54withOE. More OEs wereperformedinpatients withan unknown primary(26 vs. 3). Incidentalfindings on TNEincluded 3 cases ofgastritis, 2 cases each ofhiatal hernia and esophagitis, 1 case ofBarrett esophagus, and 1 inletpatch. No incidental findings were reported dur-ingOE. Primary cancers were biopsied by TNE through a port on the endoscope in 4 patients; 2 of these cancers were in the tongue base, 1 in thehypopharynx, and 1 in the aryepiglottic fold. After the initial visit, patients in the TNE group waited significantly fewer days for their endoscopy than did those in the OEgroup (median: 6.5 vs. 16; P < 0.05). Conversely, patients in the OEgroup waited significantly fewer days for treatment following endoscopy (median: 12 vs. 20; P < 0.05). However, there was nosignificantdifference between the TNEpatients and theOEpatients inthetotal number ofdays comprisingthe their entire course ofmanagement.from theinitial visitto definite treatment (median: 27.5 and33 days, respectively;
Introduction
The development of in-office fiberoptic transnasal esophagoscopy (TNE) has been a useful technologic advance. We previously reported our experience with TNE in a heterogeneousgroup of 30 patients and concludedthat itisahigh-yielddiagnostictool. 1 Othershave reported that TNE is useful for esophageal screening in head and neck oncology" Indeed, the valueofTNE vis-a-vis operativeand sedatedesophagoscopy hasbeen well established in terms of safety, cost savings, and patient preference.v'
In this article,we describeour experiencewith using TNEasa substitutefor traditional operativeendoscopy (OE).Wealso discussthe clinicalapplications, pitfalls, and advantages ofTNE in head and neck oncology.
Patients and methods
All patients who had presented to our institution from September 2004 through June 2006 with a new diagnosis of squamous cellcarcinoma (SCC) involving the mucosal surfacesof the oral cavity, pharynx, or larynx wereincluded in this analysis. Thegroup comprised96 patients-75 men and 21 women, aged 45 to 88 years (mean:64);therewerenosignificant differences between ENT-Ear, Nose & Throat Journal • September 2013 the two groups in age or sex. Both TNE and traditional OE were readily available and considered for all patients during the study period. The choice of which to use was based on the surgeon's judgment. The rationale for using TNE was to shorten the amount of time between the initial evaluation and definitive treatment.
We retrospectively reviewed allpatient charts. In addition to demographic data, we compiled information on tumor location and TNM category, Eastern Cooperative Oncology Group (ECOG) health status, the reason for performingTNE or OE (e.g.,initial endoscopyor biopsy), incidental findings, and procedural complications.
Tumor locations were specified as the oral cavity, oropharynx, hypopharynx, and larynx. We classified as an unknown primary any regionally metastatic SCC with no identifiable source prior to endoscopy. We also documented the date of all patients' initial visit, the date of their endoscopic procedure, and the date of their definitive surgical resection or the first day of chemotherapyor radiation therapy. Our method ofTNE is described in our previous report.'
Statistical comparisons between the TNE and OE
groups were performed with the Student t test, the chisquare (t) test, and the nonparametric Kruskal-Wallis test. Findings were considered significant at p < 0.05.
Our study was approved by the Institutional Review Board at the Lahey Clinic.
Results
Of the 96 patients, 42 underwent TNE and 54 underwent OE. After the study was closed, all but 3 patients had at least 2 years offollow-up. During that time, no patient was diagnosed with a synchronous (within 6 months of the index cancer) or metachronous cancer of the esophagus.
Clinical characteristics. According to t analysis, there were no Significant differences between the TNE and OE groups in terms of either tumor category or ECOG health status.
Tumor site. With respect to procedures according to tumor site, Significantly more TNEs than OEs were performed in patients with a tumor of the oral cavity (24 vs. 2, P < 0.05, t test), and significantly more OEs than TNEs were performed in patients with an unknown primary (26 vs. 3, P < 0.05, x: test). Of the remaining sites, 16patients had oropharyngeal cancer (7 TNE and 9 OE; all of these cancers were located in the tongue base), 3 patients had hypopharyngeal SCC (2 TNE and 1 OE), and 22 patients had laryngeal SCC (6 TNE and 16 OE) (table 1).
Incidental findings. Incidental findings reported during TNE included 3 cases of gastritis, two cases each of hiatal hernia and esophagitis (including Candida esophagitis), 1 case of Barrett esophagus, and 1 inlet patch. No incidental findings were reported during OE.
Complications. No procedural complications occurred in either group.
Biopsies. In the 42 TNE cases, 4 primary cancers were biopsied through a port on the endoscope; 2 of these cancers were in the tongue base, 1 in the hypopharynx, and 1 in the aryepiglottic fold (figure). Ofthe remaining cases, 30 biopsies were performed as an in -office procedure, and 8 were performed at a referring institution.
In 30 of the 54 OE cases, either the primary cancer was Patients in the 0 Egroup waited significantlyfewer days for treatment following endoscopy than did those in the TNE group (median: 12 vs. 20;P<0.05, Kruskal-Wallis test), chiefly because 20 of them underwent definitive surgery the same day as their surveillance endoscopy (table 2) .
There was no significant difference between the TNE patients and the OE patients in the total number of days comprising their entire course of management, from the initial visit to definite treatment (median: 27.5 and 33 days, respectively; p = 0.7, Kruskal-Wallis test). When data on the 20 OE patients who received their treatment the same day as their endoscopy were excluded from the analysis (leaving 32 TNE patients and 26 OE patients), the number of days between the initial visit and treatment remained statistically not Significant (median: 28 vs. 36; P> 0.05, Kruskal-Wallis test).
Discussion
We found that TNE is a safe and reliable alternative to OE for the initial workup of patients with SCC of the head and neck. OE was still preferred for the workup of unknown primarycancers because it allows for directed biopsies and/or tonsillectomy. Our study demonstrated the high diagnostic yield ofTNE with regard to incidental gastric and esophageal pathology. TNE was useful for obtaining tissue for histology at sites throughout Volume 92, Number 9
Figure. A: TNE view captured duringvideoendoscopy shows the tumor alongthe rightaryepiglottic fold with some minor oozing secondary to a biopsy performedthrough the scope's biopsy port. B: Viewofa second-pass biopsy shows theforceps openand about tograsp the tumor.
the upper aerodigestive tract, including the base of the tongue, hypopharynx, and larynx.
Since TNE can be performed quickly and easily as an outpatient procedure, we expected to find that patients would undergo TNE and definitive therapy much more quickly than did the patients evaluated by OE. And while the ease of scheduling and performing TNE did result in significantly fewer days from the initial visit to endoscopy, there was no such significantly shorter interval between endoscopy and definitive therapy. This finding is likely attributable to the fact that OE was often performed just prior to the definitive surgical procedure while the patient remained under the same dose ofgeneral anesthesia. One would expect that TNE patients whose definitive treatment consists of radiation therapy would experience a much shorter interval between endoscopy and treatment.
Although TNE was useful for SCCs in most sites, it does have its limitations. For example, assessing the extent of the contiguous spread of tongue base cancers can be difficultwithout manual manipulation with a rigid scope or by palpation. This is particularly true for larger tumors that obscure the surrounding landmarks such www.entjournal.com • 453 as the vallecula and epiglottis. Six of the 7 tongue base cancers that were evaluated byTNE were small (category Tl or T2). OE is preferred for cases of advanced cancer because it allows for direct tissue manipulation, thereby facilitating the assessment of spread to contiguous structures. Also, OE is preferred over TNE for directed biopsies and/or tonsillectomy.
In modern clinical practice, most esophagoscopies are performed with large-caliber endoscopes and sedation. Otolaryngologists have relinquished much of our clinical hold on esophagoscopy to gastroenterologists and their large scopes. However, with the advent of TNE, esophagoscopy is moving back into mainstream otolaryngology practice, as gastroenterologists have been slow to adopt this new technology. It is likely that otolaryngologists embraced TNE because of its many similarities to fiberoptic laryngoscopy. Still, any new technique or device is subject to enthusiastic overuse, and TNE is no exception.
Our initial experience with TNE showed that it is a high-yield diagnostic tool when used for a variety of indications. In our earlier review of 30 TNEs, we found that nearly 50% of patients had an incidental finding, including esophagitis and Barrett esophagus (the two most common diagnoses).1 Now we rarely perform rigid esophagoscopy, reserving it (1) to examine patients with head and neck cancer who are already undergoing direct laryngoscopy for biopsy and/or to assess the extent of the primary cancer, (2) to perform surveillance the day of surgery in patients who have a biopsy-proven cancer, and (3) to search for an unknown primary. This makes sense given that the diagnostic value ofTNE is reported to be equivalent to that of rigid endoscopy in terms of detecting synchronous cancers. ' In our experience, described in our previous report, we had not incorporated biopsy with TNE.l We have since done so, as is reflected in our experience reported here. This ability allows us to expand the indications for TNE in head and neck oncology. This is especially relevant in cases of laryngeal pathology where palpation or manual manipulation of tissue is not generally needed to determine the extent of tumor.
Although we detected no synchronous primary cancers in our patients, the need for surveillance endoscopy is clear based on several population studies and metaanalyses." Newer modalities such as F18-fluorodeoxyglucose-positron-emission tomography (FDG-PET) and FDG-PET with computed tomography have been reported to detect synchronous cancers with sufficient sensitivity to make panendoscopy unnecessary," However, in more recent and better controlled studies, investigators have disputed this finding, contendingthat FDG-PET cannot detect early cancers because most synchronous cancers present early(i.e.,categoryT1).10As a result, these investigators argue that FDG-PET yields many false-negative findings, and therefore endoscopy should remain the standard of care. 10 Overall, synchronous primary cancers occur in approximately 2% of patients with head and neck cancer, usually in the upper aero digestive tract. 11Approximately 10% of these occur within the esophagus, and most of them are found in association with a cancer involving the hypopharynx and in patients with a history of high alcoholconsumption.S,12.13Most second neoplasms, while still occurring within the upper aerodigestive tract, are metachronous, and they usually occur within 2 years of the diagnosis of the index cancer.
Although welimited our study to the use ofTNE in the initial workup, using it for episodic routine surveillance within the first 2years after diagnosis of the index cancer may be beneficial.14In-officeevaluation for synchronous primary cancers with TNE usually does not involve routine bronchoscopy. The inclusion of bronchoscopy in the workup (i.e., triple endoscopy) is controversial in patients with a normal chest CT because the detection rate for an endobronchial synchronous cancer is on the order ofless the 1%. 13 Wedo not routinely perform bronchoscopy, even on our patients who are undergoing OE.
In conclusion, we find that TNE is a reasonable alternative to OE for the initial screening for synchronous esophageal cancers in patients with SCC of the head and neck. At our clinic, OE is preferred for the initial workup of unknown primary cancers and large tongue base cancers. The detection rate of clinically relevant incidental findings is higher with TNE than with OE. Biopsy is possible during TNE at all subsites within the upper aero digestive tract.
